1 Blue-Chip Dividend Stock That Still Has Room to Run This pharmaceutical leaders offers a combination of growth, income, and innovation. Barchart · Jul 31, 2025
Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks. Benzinga · Jul 30, 2025
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges Merck Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst consensus but overall sales experiencing a slight year-over-year decline and missing revenue expectations. Benzinga · Jul 29, 2025
After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact Chinese biotech company Hengrui Pharma partnered with GSK plc (NYSE:GSK) on Monday to develop up to 12 medicines. Benzinga · Jul 28, 2025
How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings Merck Co., Inc. (NYSE:MRK) will release earnings results for the second quarter before the opening bell on Tuesday, July 29. Benzinga · Jul 28, 2025
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the… Benzinga · Jul 26, 2025
Stocks Settle Higher on Tech Stock Strength and Lower Bond Yields The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.72%. September E-mini S&P futures (ESU25 ) are up +0.57%, and September E-mini Nasdaq futures... Barchart · Jul 9, 2025
Stocks Climb on Strength in the Magnificent Seven Stocks The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.28%. September E-mini S&P futures (ESU25 ) are up +0.22%, and September E-mini Nasdaq futures... Barchart · Jul 9, 2025
What You Need To Know Ahead of Merck's Earnings Release Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip. Barchart · Jul 9, 2025
Stocks See Support as Investors Await Tariff News The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. September E-mini S&P futures (ESU25 ) are up +0.56%, and September E-mini Nasdaq futures... Barchart · Jul 9, 2025
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts and former federal officials after its first meeting strayed sharply from established scientific review norms. Benzinga · Jun 26, 2025
First meeting of new CDC vaccine panel reveals policy chaos sown by RFK Jr Health secretary unilaterally appointed ACIP’s eight new members, several of whom are critical of immunizations The Guardian - US · Jun 25, 2025
Merck exec says Chernobyl changed the course of her life after her father begged her to leave nuclear physics on his deathbed Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment because ‘it has fundamentally changed me as a person’. Fortune · Jun 17, 2025
Could the answers to cancer lie in space? Why off-Earth research is heating up The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — and someday even treat it. Space · Jun 13, 2025
The Independent UK · Jun 12, 2025 Meet the vaccines skeptics that are now part of RFK Jr.’s vaccine approval committee The Health and Human Services leader made shock waves when he dismissed all 17 former members on Monday
Kiplinger · May 14, 2025 Stock Market Today: Nasdaq Outperforms as Big Tech Rallies The Dow Jones Industrial Average closed lower for a second day as Amgen and Merck fell.
Barchart · May 6, 2025 Are Wall Street Analysts Bullish on Merck Stock? While Merck has trailed the broader market over the past year, analysts still see a reasonably promising path ahead for the pharma heavyweight.
The Guardian - UK · Apr 24, 2025 US drug firm Merck says existing Trump tariffs will cost it $200m this year Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports
Barchart · Apr 22, 2025 Option Volatility And Earnings Report For April 22-24 Earnings season heats up this week with all eyes on Tesla and Alphabet. Other big names reporting this week include Intel, Verizon, Nemont Mining, Boeing, Chipotle Mexican Grill, Proctor & Gamble and Merck.
Barchart · Apr 19, 2025 Streak Analysis Alert: Why Merck (MRK) Should Be on Your Radar This Week Blue chips like MRK stock generally represent a 50/50 wager for any given week. However, certain conditions strongly tilt the odds toward one side of the spectrum.
The Conversation · Apr 16, 2025 The sudden dismissal of public records staff at health agencies threatens government accountability Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, announced on March 27, 2025, to shrink its workforce by 20,000 people. Among workers dismissed in early April were several teams responsible for fulfilling requests for access to previously unreleased…
Barchart · Apr 14, 2025 What to Expect From Merck & Co.'s Next Quarterly Earnings Report Merck & Co. will release its first-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.
Fortune · Apr 2, 2025 Analysts at Trump ally Howard Lutnick’s former firm call RFK Jr. ‘an anti-vax, conspiracy theorist with inadequate training’ RFK Jr. was reportedly behind the ouster of FDA’s top vaccine official and said last week that around 10,000 employees will be laid off at the Department of Health and Human Services.
Barchart · Mar 28, 2025 Merck Stock Just Reminded Us Why ‘Buy the Dip’ Is Not That Simple This healthcare company is down more than 30% over the past 52 weeks but still may not be a good buy for value investors.
Barchart · Feb 28, 2025 Is Merck Stock Underperforming the S&P 500? Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.